These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 32561125)

  • 1. Ovarian cancer symptoms, routes to diagnosis and survival - Population cohort study in the 'no screen' arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
    Dilley J; Burnell M; Gentry-Maharaj A; Ryan A; Neophytou C; Apostolidou S; Karpinskyj C; Kalsi J; Mould T; Woolas R; Singh N; Widschwendter M; Fallowfield L; Campbell S; Skates SJ; McGuire A; Parmar M; Jacobs I; Menon U
    Gynecol Oncol; 2020 Aug; 158(2):316-322. PubMed ID: 32561125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian cancer symptoms in pre-clinical invasive epithelial ovarian cancer - An exploratory analysis nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
    Dilley J; Gentry-Maharaj A; Ryan A; Burnell M; Manchanda R; Kalsi J; Singh N; Woolas R; Sharma A; Williamson K; Mould T; Fallowfield L; Campbell S; Skates SJ; McGuire A; Parmar M; Jacobs I; Menon U
    Gynecol Oncol; 2023 Dec; 179():123-130. PubMed ID: 37980767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating Cost-effectiveness of a Multimodal Ovarian Cancer Screening Program in the United States: Secondary Analysis of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
    Moss HA; Berchuck A; Neely ML; Myers ER; Havrilesky LJ
    JAMA Oncol; 2018 Feb; 4(2):190-195. PubMed ID: 29222541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
    Menon U; Gentry-Maharaj A; Burnell M; Singh N; Ryan A; Karpinskyj C; Carlino G; Taylor J; Massingham SK; Raikou M; Kalsi JK; Woolas R; Manchanda R; Arora R; Casey L; Dawnay A; Dobbs S; Leeson S; Mould T; Seif MW; Sharma A; Williamson K; Liu Y; Fallowfield L; McGuire AJ; Campbell S; Skates SJ; Jacobs IJ; Parmar M
    Lancet; 2021 Jun; 397(10290):2182-2193. PubMed ID: 33991479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the malignant potential of ovarian inclusion cysts in postmenopausal women within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a prospective cohort study.
    Sharma A; Gentry-Maharaj A; Burnell M; Fourkala EO; Campbell S; Amso N; Seif MW; Ryan A; Parmar M; Jacobs I; Menon U;
    BJOG; 2012 Jan; 119(2):207-19. PubMed ID: 21762355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of hysterectomy and invasive epithelial ovarian and tubal cancer: a cohort study within UKCTOCS.
    Taylor JA; Burnell M; Ryan A; Karpinskyj C; Kalsi JK; Taylor H; Apostolidou S; Sharma A; Manchanda R; Woolas R; Campbell S; Parmar M; Singh N; Jacobs IJ; Menon U; Gentry-Maharaj A
    BJOG; 2022 Jan; 129(1):110-118. PubMed ID: 34555263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time to diagnosis of Type I or II invasive epithelial ovarian cancers: a multicentre observational study using patient questionnaire and primary care records.
    Lim A; Mesher D; Gentry-Maharaj A; Balogun N; Widschwendter M; Jacobs I; Sasieni P; Menon U
    BJOG; 2016 May; 123(6):1012-20. PubMed ID: 26032603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial.
    Jacobs IJ; Menon U; Ryan A; Gentry-Maharaj A; Burnell M; Kalsi JK; Amso NN; Apostolidou S; Benjamin E; Cruickshank D; Crump DN; Davies SK; Dawnay A; Dobbs S; Fletcher G; Ford J; Godfrey K; Gunu R; Habib M; Hallett R; Herod J; Jenkins H; Karpinskyj C; Leeson S; Lewis SJ; Liston WR; Lopes A; Mould T; Murdoch J; Oram D; Rabideau DJ; Reynolds K; Scott I; Seif MW; Sharma A; Singh N; Taylor J; Warburton F; Widschwendter M; Williamson K; Woolas R; Fallowfield L; McGuire AJ; Campbell S; Parmar M; Skates SJ
    Lancet; 2016 Mar; 387(10022):945-956. PubMed ID: 26707054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive value of symptoms for ovarian cancer: comparison of symptoms reported by questionnaire, interview, and general practitioner notes.
    Lim AW; Mesher D; Gentry-Maharaj A; Balogun N; Jacobs I; Menon U; Sasieni P
    J Natl Cancer Inst; 2012 Jan; 104(2):114-24. PubMed ID: 22247022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colorectal cancer ascertainment through cancer registries, hospital episode statistics, and self-reporting compared to confirmation by clinician: A cohort study nested within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
    Thomas DS; Gentry-Maharaj A; Ryan A; Fourkala EO; Apostolidou S; Burnell M; Alderton W; Barnes J; Timms JF; Menon U
    Cancer Epidemiol; 2019 Feb; 58():167-174. PubMed ID: 30616086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
    Menon U; Gentry-Maharaj A; Hallett R; Ryan A; Burnell M; Sharma A; Lewis S; Davies S; Philpott S; Lopes A; Godfrey K; Oram D; Herod J; Williamson K; Seif MW; Scott I; Mould T; Woolas R; Murdoch J; Dobbs S; Amso NN; Leeson S; Cruickshank D; McGuire A; Campbell S; Fallowfield L; Singh N; Dawnay A; Skates SJ; Parmar M; Jacobs I
    Lancet Oncol; 2009 Apr; 10(4):327-40. PubMed ID: 19282241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an ovarian cancer symptom index: possibilities for earlier detection.
    Goff BA; Mandel LS; Drescher CW; Urban N; Gough S; Schurman KM; Patras J; Mahony BS; Andersen MR
    Cancer; 2007 Jan; 109(2):221-7. PubMed ID: 17154394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing trends in reproductive/lifestyle factors in UK women: descriptive study within the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
    Gentry-Maharaj A; Glazer C; Burnell M; Ryan A; Berry H; Kalsi J; Woolas R; Skates SJ; Campbell S; Parmar M; Jacobs I; Menon U
    BMJ Open; 2017 Mar; 7(3):e011822. PubMed ID: 28264823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Examining the Effects of Time to Diagnosis, Income, Symptoms, and Incidental Detection on Overall Survival in Epithelial Ovarian Cancer: Manitoba Ovarian Cancer Outcomes (MOCO) Study Group.
    Altman AD; Lambert P; Love AJ; Turner D; Lotocki R; Dean E; Popowich S; Nachtigal MW
    Int J Gynecol Cancer; 2017 Oct; 27(8):1637-1644. PubMed ID: 28704327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of symptoms for early detection of ovarian cancer.
    Rossing MA; Wicklund KG; Cushing-Haugen KL; Weiss NS
    J Natl Cancer Inst; 2010 Feb; 102(4):222-9. PubMed ID: 20110551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should we screen for ovarian cancer? A commentary on the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) randomized trial.
    Narod SA; Sopik V; Giannakeas V
    Gynecol Oncol; 2016 May; 141(2):191-194. PubMed ID: 26915499
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk of epithelial ovarian cancer in asymptomatic women with ultrasound-detected ovarian masses: a prospective cohort study within the UK collaborative trial of ovarian cancer screening (UKCTOCS).
    Sharma A; Apostolidou S; Burnell M; Campbell S; Habib M; Gentry-Maharaj A; Amso N; Seif MW; Fletcher G; Singh N; Benjamin E; Brunell C; Turner G; Rangar R; Godfrey K; Oram D; Herod J; Williamson K; Jenkins H; Mould T; Woolas R; Murdoch J; Dobbs S; Leeson S; Cruickshank D; Fourkala EO; Ryan A; Parmar M; Jacobs I; Menon U
    Ultrasound Obstet Gynecol; 2012 Sep; 40(3):338-44. PubMed ID: 22911637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the workload associated with symptoms-based ovarian cancer screening in primary care: an audit of electronic medical records.
    Lim AW; Mesher D; Sasieni P
    BMC Fam Pract; 2014 Dec; 15():200. PubMed ID: 25496012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials-an ovarian cancer exemplar.
    Kalsi JK; Ryan A; Gentry-Maharaj A; Margolin-Crump D; Singh N; Burnell M; Benjamin E; Apostolidou S; Habib M; Massingham S; Karpinskyj C; Woolas R; Widschwendter M; Fallowfield L; Campbell S; Skates S; McGuire A; Parmar M; Jacobs I; Menon U
    Trials; 2021 Jan; 22(1):88. PubMed ID: 33494753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.